Quest PharmaTech Inc. Stock Other OTC
Equities
QPTFF
CA74836M1068
Biotechnology & Medical Research
Sales 2023 | - | Sales 2024 | - | Capitalization | 4.23M 5.81M |
---|---|---|---|---|---|
Net income 2023 | -7M -9.61M | Net income 2024 | -3M -4.12M | EV / Sales 2023 | - |
Net Debt 2023 | 625K 859K | Net Debt 2024 | 283K 389K | EV / Sales 2024 | - |
P/E ratio 2023 |
-1.61
x | P/E ratio 2024 |
-1.4
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 |
-
| Free-Float | 82.88% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
Pierre Vermette
DFI | Director of Finance/CFO | - | 04-12-31 |
Eliel Bayever
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 04-06-16 | |
J. Lievonen
CHM | Chairman | - | 21-07-04 |
Jeffrey Shon
BRD | Director/Board Member | - | 21-07-04 |
1st Jan change | Capi. | |
---|---|---|
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |